| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
62,179 |
49,293 |
$2.21M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
25,254 |
22,518 |
$1.00M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
54,693 |
24,557 |
$743K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,108 |
9,440 |
$507K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,763 |
4,701 |
$376K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,890 |
3,848 |
$333K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,340 |
4,254 |
$319K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,647 |
2,588 |
$191K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,344 |
12,508 |
$181K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,744 |
7,192 |
$172K |
| 94010 |
|
6,346 |
5,410 |
$143K |
| 80053 |
Comprehensive metabolic panel |
9,761 |
9,173 |
$86K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,322 |
9,638 |
$66K |
| 99000 |
|
5,627 |
5,310 |
$58K |
| 87807 |
|
5,173 |
4,443 |
$56K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
456 |
453 |
$37K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,441 |
3,259 |
$35K |
| 99051 |
|
5,910 |
5,327 |
$23K |
| 90461 |
|
2,277 |
1,760 |
$18K |
| 94760 |
|
7,904 |
6,890 |
$16K |
| 99381 |
|
189 |
186 |
$15K |
| 92587 |
|
801 |
789 |
$14K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
864 |
832 |
$12K |
| 86308 |
|
2,236 |
2,183 |
$9K |
| 90474 |
|
999 |
983 |
$9K |
| 81003 |
|
4,917 |
4,588 |
$9K |
| 80061 |
Lipid panel |
852 |
831 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
146 |
142 |
$8K |
| 96161 |
|
3,676 |
3,633 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
619 |
595 |
$7K |
| 83655 |
|
604 |
597 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
117 |
114 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
128 |
123 |
$1K |
| 97169 |
|
67 |
66 |
$1K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
68 |
65 |
$894.66 |
| 97170 |
|
12 |
12 |
$500.00 |
| 86580 |
|
63 |
63 |
$450.92 |
| 69209 |
|
26 |
24 |
$253.16 |
| 93000 |
|
14 |
14 |
$168.98 |
| 82570 |
|
18 |
17 |
$86.94 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
37 |
37 |
$75.47 |
| 83014 |
|
12 |
12 |
$72.60 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
610 |
587 |
$24.35 |
| 90686 |
|
1,981 |
1,974 |
$23.28 |
| 90651 |
|
262 |
260 |
$0.34 |
| 90620 |
|
47 |
47 |
$0.24 |
| 90671 |
|
69 |
69 |
$0.09 |
| 90621 |
|
63 |
60 |
$0.07 |
| 90680 |
|
1,283 |
1,262 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
10,318 |
10,184 |
$0.00 |
| 90723 |
|
1,654 |
1,629 |
$0.00 |
| 90696 |
|
386 |
384 |
$0.00 |
| 90697 |
|
56 |
56 |
$0.00 |
| 90716 |
|
72 |
72 |
$0.00 |
| 91307 |
|
15 |
15 |
$0.00 |
| 90710 |
|
1,108 |
1,100 |
$0.00 |
| 90670 |
|
2,134 |
2,109 |
$0.00 |
| 90700 |
|
495 |
491 |
$0.00 |
| 90734 |
|
1,162 |
1,151 |
$0.00 |
| 90715 |
|
465 |
462 |
$0.00 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
10,305 |
10,176 |
$0.00 |
| 90648 |
|
2,161 |
2,139 |
$0.00 |
| 90633 |
|
1,253 |
1,246 |
$0.00 |
| 90707 |
|
66 |
66 |
$0.00 |